Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for Postoperative Anxiety and Depression in Adolescents
NCT06073015Phase 1Unknown
- Sponsor
- Henan Provincial People's Hospital
- Start
- Oct 2023
- Primary completion
- Dec 2024
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of esketamine in anxiety disorder and postoperative depression (2 arms), sponsored by Henan Provincial People's Hospital. Primary endpoint: Anxiety and depression scale scores at 1 month. Status: unknown.
02
Drugs
esketamine
03
Conditions
anxiety disorderpostoperative depression
Beyond the preview
Go deeper on NCT06073015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06073015.